Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: A comparison with cocaine treatment

Journal of Neurochemistry

Volumn 117, Issue 3, 2011, Pages 470-478

  Alburges, Mario E ^a   Hoonakker, Amanda J ^a   Horner, Kristen A ^a   Fleckenstein, Annette E ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

cocaine; dopamine antagonists; dynorphin; methamphetamine; methylphenidate; neurotensin

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DYNORPHIN; ETICLOPRIDE; METHYLPHENIDATE; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; GLOBUS PALLIDUS; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

RATTUS;

EID: 79954422457     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07215.x     Document Type: Article

References (61)

1. Adriani W., Leo D., Greco D., Rea M., di Porzio U., Laviola G., and, Perrone-Capano C., (2006) Methylphenidate administration to adolescent rats determines plastic changes in reward-related behavior and striatal gene expression. Neuropsychopharmacology 31, 1946-1956.
2. Alburges M. E., and, Hanson G. R., (1999) Differential response by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine. Brain Res. 818, 96-104. (Pubitemid 29227288)
3. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
4. Bogle K. E., and, Smith B. H., (2009) Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr. Drug Abuse Rev. 2, 157-176.
5. Boules M., Warrington L., McCormick D., and, Richelson E., (2001) A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. Eur. J. Pharmacol. 426, 73-76. (Pubitemid 32781790)
6. Bradford M. M., (1976) A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Brandon C. L., and, Steiner H., (2003) Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur. J. Neurosci. 18, 1584-1592. (Pubitemid 37215111)
8. Brown J. M., Hanson G. R., and, Fleckenstein A. E., (2000) Methamphetamine rapidly decreases vesicular dopamine uptake. J. Neurochem. 74, 2221-2223. (Pubitemid 30217682)
9. Castel M. N., Morino P., and, Hökfelt T., (1993) Modulation of the neurotensin striatonigral pathway by D1 receptors. Neuroreport 5, 281-284. (Pubitemid 24026254)
10. Castel M. N., Morino P., Dagerlind A., and, Hökfelt T., (1994a) Up-regulation of neurotensin mRNA in rat striatum after acute methamphetamine treatment. Eur. J. Neurosci. 6, 646-656. (Pubitemid 24106850)
11. Castel M. N., Morino P., Nylander I., Terenius L., and, Hökfelt T., (1994b) Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. Eur. J. Pharmacol. 262, 1-10. (Pubitemid 24271828)
12. Collins S. L., Levin F. R., Foltin R. W., Kleber H. D., and, Evans S. M., (2006) Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend. 82, 158-167.
13. Cotterly L., Beverley J. A., Yano M., and, Steiner H., (2007) Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a. Eur. J. Neurosci. 25, 3617-3628. (Pubitemid 47020439)
14. During M. J., Bean A. J., and, Roth R. H., (1992) Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci. Lett. 140, 129-133.
15. Faraone S. V., Spencer T., Aleardi M., Pagano C., and, Biederman J. J., (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. Clin. Psychopharmacol. 24, 24-29. (Pubitemid 38134162)
16. Frey P., Fuxe K., Eneroth P., and, Agnati L., (1986) Effects of acute and long-term treatment with neuroleptics on regional telencephalic neurotensin levels in the male rat. Neurochem. Int. 8, 429-435.
17. Fukui R., Svenningsson P., Matsuishi T., Higashi H., Nairn A. C., Greengard P., and, Nishi A., (2003) Effect of methylphenidate on dopamine/DARPP signaling in adult, but not young mice. J. Neurochem. 87, 1391-1401. (Pubitemid 38020573)
18. Gaytan O., al-Rahim S., Swann A., and, Dafny N., (1997) Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 61, 101-107.
19. Gerasimov M. R., Franceschi M., Volkow N. D., Gifford A., Gatley S. J., Marsteller D., Molina P. E., and, Dewey S. L., (2000) Comparison between intraperitoneal and oral methylphenidate administration: a microdialysis and locomotor activity study. J. Pharmacol. Exp. Ther. 295, 51-57.
20. Glimcher P. W., Margolin D. H., Giovino A. A., and, Hoebel B. G., (1984) Neurotensin: a new reward peptide. Brain Res. 291, 119-124.
21. Gygi S., Gibb J. W., and, Hanson G. R., (1994) Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions. J. Pharmacol. Exp. Ther. 270, 192-197. (Pubitemid 24229628)
22. Hanson G. R., and, Keefe K. A., (1999) Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway. Mol. Brain Res. 66, 111-121. (Pubitemid 29148339)
23. Hanson G. R., Smiley P., Johnson M., Letter A., Bush L., and, Gibb J. W., (1989) Response of neurotensin systems of the basal ganglia to cocaine treatment. Eur. J. Pharmacol. 160, 23-30. (Pubitemid 19044825)
24. Harlan R. E., and, Garcia M. M., (1998) Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16, 221-267. (Pubitemid 28268545)
25. Hernandez D. E., Stanley D. A., Melvin J. A., and, Prange Jr A. J., (1985) Role of brain neurotransmitters on neurotensin-induced gastric cytoprotection. Pharmacol. Biochem. Behav. 22, 509-513. (Pubitemid 15108224)
26. Hurd Y. L., and, Ungerstedt U., (1989) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166, 251-260. (Pubitemid 19186762)
27. Jones S. R., Gainetdinov R. R., Wightman R. M., and, Caron M. G., (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979-1986. (Pubitemid 28141404)
28. Kalivas P. W., (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18, 75-113. (Pubitemid 23090012)
29. Kuczenski R., and, Segal D. S., (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68, 2032-2037. (Pubitemid 27176139)
30. Letter A. A., Merchant K., Gibb J. W., and, Hanson G. R., (1987) Effect of methamphetamine on neurotensin concentrations in rat brain regions. J. Pharmacol. Exp. Ther. 241, 443-447. (Pubitemid 17111545)
31. Levin F. R., Evans S. M., McDowell D. M., and, Kleber H. D., (1998) Methylphenidate treatment for cocaine abusers with adult attention-deficit/ hyperactivity disorder: a pilot study. J. Clin. Psychiatry 59, 300-305. (Pubitemid 28353978)
32. Lin J. S., Hou Y., and, Jouvet M., (1996) Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in cat. Proc. Natl Acad. Sci. USA 93, 14128-14133. (Pubitemid 26424257)
33. Lopak V., and, Erb S., (2005) Activation of central neurotensin receptors reinstates cocaine seeking in rat: modulation by a D1/D5, but not D2/D3, receptor antagonist. Psychopharmacology (Berl) 182, 297-304. (Pubitemid 41464622)
34. Maidment N. T., Siddall B. J., Rudolph V. R., Erdelyi E., and, Evans C. J., (1991) Dual determination of extracellular cholecystokinin and neurotensin fragments in rat forebrain: microdialysis combined with a sequential multiple antigen radioimmunoassay. Neuroscience 45, 81-93.
35. McNamara C. G., Davidson E. S., and, Schenk S., (1993) A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacol. Biochem. Behav. 45, 729-732.
36. Merchant K. M., Letter A. A., Gibb J. W., and, Hanson G. R., (1988) Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur. J. Pharmacol. 153, 1-9.
37. Merchant K. M., Miller M. A., Ashleigh E. A., and, Dorsa D. M., (1991) Haloperidol rapidly increases the number of neurotensin mRNA-expressing neurons in neostriatum of the rat brain. Brain Res. 540, 311-314.
38. Merchant K. M., Dobner P. R., and, Dorsa D. M., (1992) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J. Neurosci. 12, 652-663.
39. Merchant K. M., Hanson G. R., and, Dorsa D. M., (1994) Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: Comparison with acute haloperidol effects. J. Pharmacol. Exp. Ther. 269, 806-812. (Pubitemid 24157355)
40. Nemeroff C., Bissette G., Prange Jr A. G., Loosen P. T., Barlow T. S., and, Lipton M. A., (1977) Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res. 128, 485-498.
41. Nemeroff C. B., Luttinger D., Hernandez D. E., et al. (1983) Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies. J. Pharmacol. Exp. Ther. 225, 337-345. (Pubitemid 13091221)
42. Nestler E. J., (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128. (Pubitemid 33673366)
43. Paxinos G., and, Watson C., (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
44. Richelson E., Boules M., and, Fredrickson P., (2003) Neurotensin agonists: possible drugs for treatment of psychostimulant abuse. Life Sci. 73, 679-690. (Pubitemid 36703262)
45. Riddle E. L., Topham M. K., Haycock J. W., Hanson G. R., and, Fleckenstein A. E., (2002) Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur. J. Pharmacol. 449, 71-74.
46. Rompre P. P., and, Bauco P., (2006) Neurotensin receptor activation sensitizes to the locomotor stimulant effect of cocaine: a role for NMDA receptors. Brain Res. 1085, 77-86. (Pubitemid 43728196)
47. Rompre P. P., Bauco P., and, Gratton A., (1992) Facilitation of brain stimulation reward by mesencephalic injections of neurotensin (1-13). Eur. J. Pharmacol. 211, 295-303.
48. Sandoval V., Riddle E. L., Hanson G. R., and, Fleckenstein A. E., (2002) Methylphenidate redistributes vesicular monoamine-2: role of dopamine receptors. J. Neurosci. 22, 8705-8710. (Pubitemid 35387611)
49. Schweri M. M., Skolnick P., Rafferty M. F., Rice K. C., Janowsky A. J., and, Paul S. M., (1985) [3H]Threo-(±)-methylphenidate binding to 3,4-dihydroxy-phenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters. J. Neurochem. 45, 1062-1070. (Pubitemid 16258150)
50. Smiley P. L., Johnson M., Bush L., Gibb J. W., and, Hanson G. R., (1990) Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253, 938-943. (Pubitemid 20209347)
51. Svetlov S. I., Kobeissy F. H., and, Gold M. S., (2007) Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine. J. Addict. Dis. 26, 1-6.
52. Thanos P. K., Michaelides M., Benveniste H., Wang G. J., and, Volkow N. D., (2007) Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol. Biochem. Behav. 87, 426-433. (Pubitemid 47248631)
53. Uhl G. R., and, Snyder S. H., (1976) Regional and subcellular distribution of brain neurotensin. Life Sci. 19, 1827-1832. (Pubitemid 8013727)
54. Volkow V. D., Ding Y. S., Fowler J. S., et al. (1995) Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 52, 456-463.
55. Volkow N. D., Wang G., Fowler J. S., et al. (2001) Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J. Neurosci. 21, 1-5.
56. Wagstaff J. D., Bush L. G., Gibb J. W., and, Hanson G. R., (1994) Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res. 665, 237-244. (Pubitemid 24356726)
57. Wilens T. E., (2003) Drug therapy for adult with attention-deficit hyperactivity disorder. Drugs 63, 2395-2411. (Pubitemid 37392906)
58. Willuhn I., Sun W., and, Steiner H., (2003) Topography of cocaine-induced gene regulation in the rat striatum: relationship to cortical inputs and role of behavioural context. Eur. J. Neurosci. 17, 1053-1066. (Pubitemid 36411602)
59. Yano M., and, Steiner H., (2005) Topography of methylphenidate (ritalin)-induced gene regulation in the striatum: differential effects on c-fos, substance P and opioid peptides. Neuropsychopharmacology 30, 901-915. (Pubitemid 40570906)
60. Yano M., and, Steiner H., (2007) Methylphenidate and cocaine: the same effects on gene regulation. Trends Pharmacol. Sci. 28, 588-596. (Pubitemid 350026614)
61. Zahm D. S., Grosu S., Williams E. A., Qin S., and, Berod A., (2001) Neurons of origin of the neurotensinergic plexus enmeshing the ventral tegmental area in rat: retrograde labeling and in situ hybridization combined. Neuroscience 104, 841-851. (Pubitemid 32607434)